These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15648944)

  • 1. Anti-angiogenic vaccines as a treatment modality for cancer.
    Plum SM; Fogler WE
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1243-6. PubMed ID: 15648944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
    Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
    Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
    Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic active immunotherapy: a new approach to cancer treatment.
    Pan J; Jin P; Yan J; Kabelitz D
    Cancer Immunol Immunother; 2008 Aug; 57(8):1105-14. PubMed ID: 18214475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule-targeting agents in angiogenesis: where do we stand?
    Pasquier E; Honoré S; Braguer D
    Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic strategies for cancer therapy (Review).
    Benouchan M; Colombo BM
    Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic drugs: from bench to clinical trials.
    Quesada AR; Muñoz-Chápuli R; Medina MA
    Med Res Rev; 2006 Jul; 26(4):483-530. PubMed ID: 16652370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumors with peptides from natural sources.
    Bhutia SK; Maiti TK
    Trends Biotechnol; 2008 Apr; 26(4):210-7. PubMed ID: 18295917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: preclinical studies and novel strategies.
    Palena C; Abrams SI; Schlom J; Hodge JW
    Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour vascular targeting.
    Neri D; Bicknell R
    Nat Rev Cancer; 2005 Jun; 5(6):436-46. PubMed ID: 15928674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA.
    Teramoto K; Kontani K; Fujita T; Ozaki Y; Sawai S; Tezuka N; Fujino S; Itoh Y; Taguchi O; Kannagi R; Ogasawara K
    Cancer Immunol Immunother; 2007 Mar; 56(3):331-42. PubMed ID: 16896967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis inhibitors in the treatment of lung cancer.
    Sun S; Schiller JH
    Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
    Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
    J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA; Singh RP
    Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches in anti-angiogenic treatment targeting endothelial F-actin: a new anti-angiogenic strategy?
    Thoenes L; Günther M
    Curr Opin Mol Ther; 2008 Dec; 10(6):579-90. PubMed ID: 19051136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy for colorectal cancer: mapping the way.
    Mocellin S; Lise M; Nitti D
    Trends Mol Med; 2005 Jul; 11(7):327-35. PubMed ID: 15950539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current immunotherapeutic strategies in renal cell carcinoma.
    Amato RJ
    Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.